You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE LIVE 15:40 | 17 Nov 1131.55 -10.00
(-0.88%)
OPEN

1160.00

HIGH

1179.00

LOW

1130.00

NSE 15:31 | 17 Nov 1139.55 -1.50
(-0.13%)
OPEN

1169.00

HIGH

1172.90

LOW

1134.05

OPEN 1160.00
PREVIOUS CLOSE 1141.55
VOLUME 3434
52-Week high 1300.00
52-Week low 666.00
P/E 34.44
Mkt Cap.(Rs cr) 963
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1160.00
CLOSE 1141.55
VOLUME 3434
52-Week high 1300.00
52-Week low 666.00
P/E 34.44
Mkt Cap.(Rs cr) 963
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.